PCPA in the news – can ‘smart bombs’ replace chemo?

pharma in focus 13 June – 16 June 2023

Posted 15 June 2023

Antibody-drug conjugates (ADCs), described as “biological missiles” and “smart bombs” against cancer, could have the potential to replace chemotherapy for metastatic breast cancer.

Speaking on the Private Cancer Physicians of Australia Podcast series, University of California San Francisco Director of Breast Oncology Professor Hope Rugo said the precise and potent surface-antibody drugs were proving effective and better tolerated than existing treatments.

“This is such an exciting topic for all of us,” Rugo said. “It pervades everything […]

PCPA in the news – Unveiling the power of empathy: Gilead joins oncologists in bridging the gap

Health Industry Hub 26 May 2023

Pharma News: In an event that showcased the cutting-edge advancements in cancer treatment, the Private Cancer Physicians of Australia (PCPA) joined forces with GenesisCare, their Strategic Alliance Partner, to successfully launch the inaugural PCPA Live Multidisciplinary Teams (MDT) Masterclass. This event witnessed healthcare leaders from Gilead Australia immerse themselves in the daily life of breast cancer patients undergoing complex treatments, providing a unique opportunity to gain invaluable insights into the challenges faced by patients and their MDT teams.

Under the esteemed guidance of PCPA Board member and renowned GenesisCare Medical Oncologist, Professor Stephen Clarke, […]